The National Institutes of Health (NIH) is offering the NIH Directors New Innovator Award Program (DP2 Clinical Trial Optional) grant opportunity. This grant aims to support early stage investigators who propose bold and highly innovative research projects with the potential to make a significant impact on important areas relevant to the mission of NIH. The program encourages applications from individuals from diverse backgrounds and institutions across all geographic locations. The grant is open to various topics, including behavioral, social, biomedical, applied, and formal sciences, as well as basic, translational, or clinical research. The NIH Directors New Innovator Award Program is part of the High-Risk, High-Reward Research (HRHR) Program of the NIH Common Fund. For more information and to apply, visit the following link: NIH Directors New Innovator Award Program.